Estimates mortality risk in Stevens–Johnson syndrome and toxic epidermal necrolysis.
Overview
Estimates mortality risk in Stevens–Johnson syndrome and toxic epidermal necrolysis.
Clinical Significance
Use this result as structured clinical decision support within the validated population and setting.
When to Use
- Use when this published instrument is clinically appropriate and all required data are available.
How It Is Calculated
- MedicalC applies the published item weights, equation and interpretation bands.
Interpretation
- Interpret the result alongside examination, investigations, trajectory and current guidance.
Worked Example
Enter verified values for every field. MedicalC applies the published method and displays the resulting category.
Limitations
- Performance depends on correct eligibility and measurement.
- Thresholds support rather than replace clinical judgement.
Clinical Pearls
- Record the individual inputs as well as the total result.
- Reassess when clinical status changes.
Common Mistakes
- Using measurements from the wrong time point.
- Treating a prediction score as a diagnosis or mandatory treatment instruction.
Frequently Asked Questions
What does this tool calculate?
Estimates mortality risk in Stevens–Johnson syndrome and toxic epidermal necrolysis.
Can the result be used alone?
No. It must be integrated with a complete clinical assessment.
References
- Bastuji-Garin S et al. J Invest Dermatol. 2000;115:149-153. — Primary or supporting reference for the implemented method.
Reviewed by: MedicalC Clinical Editorial Team
Last reviewed: July 2026